Experian


Q3 in line with expectations

14/01/22 -"Experian reported its Q3 revenue update which was largely in line with our expectations and management’s guidance. The organic growth of 11% yoy, which sits at the upper end of management’s ..."

Pages
47
Language
English
Published on
14/01/22
You may also be interested by these reports :
21/10/25
Eurofins Scientific’s Q3 results were broadly in line with our expectations and Visible Alpha consensus. The organic growth was slightly below ...

07/10/25
FICO’s launch of the Mortgage Direct Licence Programme – which allows resellers to obtain scores directly from them, thereby bypassing credit ...

23/09/25
After a decent close to 2024 (i.e. March-end FY25), management guidance for 2025 seemed overambitious, given the macro environment, especially ...

04/09/25
The change in the target price reflects the update of our estimates and the effect on DCF and peer-based valuations. Despite a challenging macro ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO